Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Braun

Showing results (341-350 of 369) with videos related to

Pageof 37
Sort By:
Nature Genetics|May 31, 2001
Identification of the gene that, when mutated, causes the human obesity syndrome BBS4K Mykytyn, T Braun, R Carmi, et al.
Stroke|October 31, 2014
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke AssociationJames F Meschia, Cheryl Bushnell, Bernadette Boden-Albala, et al.
Journal of Clinical Lipidology|October 11, 2011
Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialistsMichael H Davidson, Christie M Ballantyne, Terry A Jacobson, et al.
Circulation|August 10, 2016
Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke AssociationLynne T Braun, Kathleen L Grady, Jean S Kutner, et al.
Stroke|December 4, 2010
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationLarry B Goldstein, Cheryl D Bushnell, Robert J Adams, et al.
Journal of the American College of Cardiology|September 2, 2017
Optimizing Cholesterol Treatment in Patients With Muscle ComplaintsRobert S Rosenson, Steven Baker, Maciej Banach, et al.
Annals of Hematology|January 30, 2013
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFMC Kelaidi, O Beyne-Rauzy, T Braun, et al.
BMC Cancer|October 4, 2017
TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trialD Wittmann, A Mehta, L Northouse, et al.
The Lancet. Respiratory Medicine|January 5, 2025
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trialsClaire Keating, Lael M Yonker, François Vermeulen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 2, 2026
Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosisEva Van Braeckel, Andrew T Braun, Nicholas J Simmonds, et al.
Pageof 37

Showing results (341-350 of 369) with videos related to

Sort By:
Pageof 37
Nature Genetics|May 31, 2001
Identification of the gene that, when mutated, causes the human obesity syndrome BBS4K Mykytyn, T Braun, R Carmi, et al.
Stroke|October 31, 2014
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke AssociationJames F Meschia, Cheryl Bushnell, Bernadette Boden-Albala, et al.
Journal of Clinical Lipidology|October 11, 2011
Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialistsMichael H Davidson, Christie M Ballantyne, Terry A Jacobson, et al.
Circulation|August 10, 2016
Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke AssociationLynne T Braun, Kathleen L Grady, Jean S Kutner, et al.
Stroke|December 4, 2010
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationLarry B Goldstein, Cheryl D Bushnell, Robert J Adams, et al.
Journal of the American College of Cardiology|September 2, 2017
Optimizing Cholesterol Treatment in Patients With Muscle ComplaintsRobert S Rosenson, Steven Baker, Maciej Banach, et al.
Annals of Hematology|January 30, 2013
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFMC Kelaidi, O Beyne-Rauzy, T Braun, et al.
BMC Cancer|October 4, 2017
TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trialD Wittmann, A Mehta, L Northouse, et al.
The Lancet. Respiratory Medicine|January 5, 2025
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trialsClaire Keating, Lael M Yonker, François Vermeulen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 2, 2026
Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosisEva Van Braeckel, Andrew T Braun, Nicholas J Simmonds, et al.
Pageof 37